109146 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A. MicroRNAs, miRNAs
COMBINATION CANCER THERAPY WITH C-MET INHIBITORS AND SYNTHETIC OLIGONUCLEOTIDES
#1802NANOCARRIER SYSTEM FOR MICRORNAS AND USES THEREOF
#1803AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTION
#1804Age-related macular degeneration treatment
#1805Micro-RNA family that modulates fibrosis and uses thereof
#1806Micro-RNA family that modulates fibrosis and uses thereof
#1807Micro-RNA family that modulates fibrosis and uses thereof
#1808Method of treating intracellular infection
#1809Identification of a resistance gene from pepper () and method for generating plants with resistance
#1810MicroRNA and methods for inhibiting same
#1811Anti-miR-27b and anti-miR-148a oligonucleotides as therapeutic tools for treating dyslipidemias and cardiovascular diseases
#1812Microrna and uses in brown fat differentiation
#1813MICRORNA DOSING REGIMENS
#1814Isolation of novel AAV's and uses thereof
#1815NUCLEOTIDE SEQUENCE MOTIFS DIRECTING NUCLEIC ACID LOCATION TO EXTRACELLULAR VESICLES
#1816Methods for maturing cardiomyocytes and uses thereof
#1817SHIP INHIBITION TO COMBAT OBESITY
#1818Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer
#1819METHODS OF TREATING ATHEROSCLEROSIS
#1820Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
#1821Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#1822LUNG CANCER DIAGNOSTICS AND THERAPEUTICS WITH MIR-660
#1823Methods for diagnosing and treating learning or mental disorders
#1824Targeting microRNAs for the treatment of fibrosis
#1825Inflammatory disease diagnosis and methods of treatment using lipopolysaccharides-responsive beige-like anchor
#1826Method of isolating nucleic acid
#1827Methods to prevent and treat autosomal dominant non-syndromic hearing loss
#1828Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism
#1829Regulator targetting fatty acid synthase and method of using the same for improving meat quality
#1830MiRNA for regulating FABP6 gene and method of using the same
#1831METHODS, SYSTEMS, AND COMPOSITIONS RELATING TO TREATMENT OF NEUROLOGICAL CONDITIONS, DISEASES, AND INJURIES AND COMPLICATIONS FROM DIABETES
#1832Pharmaceutical composition for treating liver diseases
#1833DIAGNOSTIC AND THERAPEUTIC METHODS RELATING TO MICRORNA-144
#1834miR-29 mimics and uses thereof
#1835Cancer treatment methods using remote conditioning
#1836Compositions and Methods for Evaluating Heart Failure
#1837Synthetic mimics of miR-124
#1838Huntington's disease therapeutic compounds
#1839METHOD OF REGULATING NFATC2 ACTIVITY IN LYMPHOCYTES
#1840Compositions and methods for reducing neointima formation
#1841RNAi-mediated inhibition of histamine receptor H1-related conditions
#1842SYNTHETIC MIMICS OF MIR-34
#1843Composition for controlling stem cells pluripotency, containing LIN28A methylation inhibitor, and method for screening for LIN28A methylation inhibitor
#1844Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy
#1845Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#1846Viral and viral associated miRNAs and uses thereof
#1847Targeting microRNAs for the treatment of liver cancer
#1848Targeting microRNAs for metabolic disorders
#1849HSA-MIR-146B-5P-related nucleic acids and uses thereof
#1850Signal activated RNA interference
#1851Inhibitors of Hemopoietic Cell Kinase (P59-HCK) and Their Use in the Treatment of Influenza Infection
#1852Long interfering nucleic acid duplexes targeting multiple RNA targets
#1853Modified Poly(Beta-Amino Ester)s for Drug Delivery
#1854Method of deriving mature hepatocytes from human embryonic stem cells
#1855Role for the perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway
#1856miRNA BIOGENESIS IN EXOSOMES FOR DIAGNOSIS AND THERAPY
#1857Methods for including cardiomyocyte proliferation
#1858MiR-204 and miR-211 and uses thereof
#1859Medicament for liver regeneration and for treatment of liver failure
#1860MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT
#1861MICRORNAS AS FUNCTIONAL MEDIATORS AND BIOMARKERS OF BONE METASTASIS
#1862Method for expressing, secreting and transferring functional microRNAs/siRNAs and application thereof
#1863Selective targeting of cancer stem cells
#1864METHODS OF INCREASING INSULIN CONTENT IN CELLS
#1865Method for treating and/or preventing myopia
#1866Immunomodulation by controlling expression levels of microRNAs in dendritic cells
#1867MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF DISEASES ASSOCIATED WITH EPITHELIAL MESENCHYMAL TRANSITION
#1868NUCLEIC ACIDS INVOLVED IN VIRAL INFECTION
#1869miRNA profiling compositions and methods of use
#1870Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions
#1871Segmented micro RNA mimetics
#1872CELL LINES FOR VIRUS PRODUCTION AND METHODS OF USE
#1873Furin-knockdown bi-functional RNA
#1874Genetic control method and compositions against insect pests in cotton plants by the silencing of genes of the laccase family
#1875METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1876MiRNA targets
#1877Plants as functional microRNA and/or functional siRNA carriers, preparation methods and uses thereof
#1878Methods and compositions involving miRNA and miRNA inhibitor molecules
#1879Oligonucleotides for modulation of target RNA activity
#1880RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis
#1881METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1882Methods and compositions involving miRNA and miRNA inhibitor molecules
#1883Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
#1884Methods and compositions to modulate RNA processing
#1885Biological control of coleopteran pests
#1886Biomarkers and treatments for heart failure
#1887MiRNA modulators of thermogenesis
#1888MODULATION OF MYOFIBER REPAIR BY ANTI-MYOSTATIN STRATEGIES AND/OR PPAR GAMMA LIGANDS, ALONE OR IN COMBINATION WITH STEM CELLS, FOR THE THERAPY OF CRITICAL LIMB ISCHEMIA AND OTHER ISCHEMIC PROCESSES AFFECTING THE SKELETAL MUSCLE
#1889Compositions and methods for diagnosis, prognosis and treatment of hematological malignancies
#1890Treatment of B-cell lymphoma with microRNA
#1891Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy
#1892Transferrin/transferrin receptor-mediated siRNA delivery
#1893Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
#1894Identification of novel genes coding for small temporal RNAs
#1895Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1896Method of rapidly inducing large-scale and high-purity mesenchymal stem cells to transdetermine into hematopoietic stem cells
#1897Composition and method for treating a hematological malignancy
#1898ANOIKIS RESISTANT PLACENTAL STEM CELLS AND USES THEREOF
#1899miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers
#1900Competitive modulation of microRNAs
#1901Transgenic plants with modified sugar content and methods of generating same
#1902Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#1903METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1904MICROMIRs
#1905Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
#1906Inhibition of histone methyltransferase for cardiac reprogramming
#1907Treatment of angiogenesis disorders
#1908Cell capable of producing adeno-associated virus vector
#1909Extraction, preparation, and application of plant micro-ribonucleic acid
#1910Diagnosis and treatment of endometriosis
#1911METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1912METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1913miRNA169 compositions and methods for the regulation of carbohydrate metabolism and flowering in plants
#1914THY1 (CD90) as a novel therapy to control adipose tissue accumulation
#1915Method for establishing modified host cell
#1916METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#1917Inhibiting migration of cancer cells
#1918COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY
#1919Polypeptides having peroxygenase activity
#1920Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
#1921Lipidosome preparation, preparation method and application thereof
#1922METHOD OF PROGNOSIS AND STRATIFICATION OF OVARIAN CANCER
#1923MicroRNAs and Methods of Using Same
#1924Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1925Transgenic Plants With RNA Interference-Mediated Resistance Against Root-Knot Nematodes
#1926Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#1927Polypeptides having peroxygenase activity
#1928MIR-21 PROMOTER DRIVEN TARGETED CANCER THERAPY
#1929Nanotubes as carriers of nucleic acids into cells
#1930Nanocarriers and their processing for diagnostics and therapeutics
#1931Targets in multiple myeloma and other disorders
#1932METHOD FOR SCREENING MICRORNAS WITH GENE SILENCING FUNCTION AT BOTH LEVELS OF TRANSCRIPTION AND POST-TRANSCRIPTION
#1933Polypeptides having peroxygenase activity
#1934Pharmaceutical composition comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-202-5P inhibitor for inhibiting cancer
#1935MIRNA MODULATORS OF CHRONIC VISCERAL INFLAMMATION
#1936POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF
#1937Transgenic plant of the species solanum tuberosum with resistance to phytophthora
#1938Methods and compositions using miR-3151 in the diagnosis and treatment of cancer
#1939PHARMACEUTICAL COMPOSITION FOR TREATING LIVER DISEASES
#1940MiRNA for treating head and neck cancer
#1941Compositions and methods for treating peripheral arterial disease
#1942PROMOTER OF DIFFERENTIATION FROM HEPATIC PROGENITOR CELL INTO HEPATIC CELL, AND USE THEREOF
#1943Exosome-based therapeutics against neurodegenerative disorders
#1944CELL-SPECIFIC DELIVERY OF MIRNA MODULATORS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS
#1945MIR-18B for use as a marker of cancer progression and target for therapies to treat cancer
#1946MicroRNA-198 as a tumor suppressor in ovarian cancer
#1947Post-synthetic chemical modification of RNA at the 2′-position of the ribose ring via “click” chemistry
#1948MIRNA MODULATORS OF THERMOGENESIS
#1949Therapeutic method for pancreatic cancer
#1950Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes
#1951MicroRNA-based approach to treating malignant pleural mesothelioma
#1952Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
#1953CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION
#1954Exosomes and micro-ribonucleic acids for tissue regeneration
#1955Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#1956Compositions for targeted delivery of siRNA
#1957DOWNREGULATION OF miR-218 MAY BE USED AS A BIOMARKER FOR HUMAN ALS
#1958Method for controlling flowering time by regulating of SVP-FLM-β protein complex formation
#1959Structurally designed shRNAs
#1960Agent for treating cancer
#1961Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection
#1962INHIBITORS OF NKX2.5 FOR VASCULAR REMODELLING
#1963Simultaneous detection of cannibalism and senescence as prognostic marker for cancer
#1964Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same
#1965Nucleic acids for down-regulation of gene expression
#1966Amine-containing transfection reagents and methods for making and using same
#1967Acellular pro-tolerogenic compositions and process for making same
#1968Methods and compositions for universal detection of nucleic acids
#1969Oligomeric compounds and methods
#1970Gene vector
#1971Plant microRNAs and methods of use thereof
#1972Compositions and methods for inhibition of nucleic acids function
#1973Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
#1974miR-520 microRNAs sensitize cancers to platinum-based therapy
#1975MicroRNAs
#1976Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery
#1977HEXIM-1 AS A TARGET OF LEPTIN SIGNALING TO REGULATE OBESITY AND DIABETES
#1978Methods of treating vascular inflammatory disorders
#1979NUCLEIC ACID MOLECULES AND COLLECTIONS THEREOF, THEIR APPLICATION AND MODIFICATION
#1980Chemical modification of short small hairpin RNAs for inhibition of gene expression
#1981siRNA compounds comprising terminal substitutions
#1982Isoform of Bruton's Tyrosine Kinase (BTK) Protein
#1983Expression Construct for a Lin28-Resistant Let-7 Precursor MicroRNA
#1984DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS
#1985Composition comprising miRNA for enhancing radiation sensitivity
#1986CELL ENGINEERING USING RNAs
#1987Therapeutic micro RNA targets in chronic pulmonary diseases
#1988Manipulating microRNA for the management of neurological diseases or conditions and compositions related thereto
#1989Methods and compositions useful for diagnosing inflammatory bowel disease-associated neoplasia
#1990Compositions and kits for molecular counting
#1991TREATMENT OF CANCER
#1992miR-200 Family Induces Mesenchymal-to-Epithelial Transition (MET) in Ovarian Cancer Cells
#1993Method of reducing the number of EMT and MET type breast cancer stem cells
#1994Methods and compositions for the treatment of insulin-associated medical conditions
#1995Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
#1996Methods and compositions for modulating MIR-204 activity
#1997METHOD OF THERAPY AND DIAGNOSIS OF ENDOTHELIAL DYSFUNCTION
#1998Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#1999Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics
#2000MicroRNA compounds and methods for modulating miR-122
#2001LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#2002NEURONAL DIFFERENTIATION PROMOTER
#2003MiRNA-31 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC AGENT IN CANCER
#2004Rational design of microRNA-siRNA chimeras for multi-functional target suppression
#2005Method of regulating gene expression
#2006Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis
#2007Targeted and modular exosome loading system
#2008Micro-RNAs involved in macular degeneration
#2009MICRORNA COMPOSITIONS AND METHODS
#2010Lipid-derived neutral nanoparticles
#2011Cancer-related extracellular matrix signatures and related methods and products
#2012Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#2013STEM CELL MICROPARTICLES
#2014Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD
#2015THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS
#2016Neurofibromatoses therapeutic agents and screening for same
#2017REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#2018MEDICINAL COMPOSITION FOR TREATING INFARCTION
#2019RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
#2020DNA controlling miR-140 expression, and screening method of drugs using said DNA
#2021INHIBITORS OF NOX4 EXPRESSION AND /OR NOX4 FUNCTION AND THEIR USE IN THE PREVENTION AND TREATMENT OF NERVE INJURY AND/OR NEUROPATHIC PAIN
#2022Trans-acting RNA switches
#2023Use of the chromosome 19 microRNA cluster (C19MC) for treating viral disease and promoting authophagy
#2024Pain treatment
#2025METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING
#2026Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms
#2027Esophageal microRNA expression profiles in eosinophilic esophagitis
#2028Precursor miRNA loop-modulated target regulation
#2029Use of miR-23a-3p and/or miR-27a-3p mimics as therapeutic agents for inhibition of neuronal apoptosis following brain injury
#2030Generation of neural stem cells and motor neurons
#2031MicroRNAs for the generation of astrocytes
#2032Methods of modulating smooth muscle cell proliferation and differentiation
#2033Compositions and methods for treatment of ovarian cancer
#2034BIOMARKER, USES THEREOF AND THERAPY
#2035RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE
#2036MiRNA analysis methods
#2037Increasing taxane sensitivity in cancer cells
#2038Embryonic stem cell specific microRNAs promote induced pluripotency
#2039Targeting RNAs to microvesicles
#2040MODIFIED MIRNA AS A SCAFFOLD FOR SHRNA
#2041Treatment of disease by modulation of SIRT6
#2042MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation
#2043CMV GENE PRODUCTS PROMOTE CANCER STEM CELL GROWTH
#2044Internal reference genes for microRNAs normalization and uses thereof
#2045Cancer diagnostics using non-coding transcripts
#2046Use of microrna molecules to influence skin pigmentation
#2047Methods for diagnosing and treating learning or mental disorders
#2048Methods and compositions for reducing viral genome amounts in a target cell
#2049Lipid particle, nucleic acid transfer carrier, compound for manufacturing nucleic acid transfer carrier, method for manufacturing lipid particle, and gene transfer method
#2050Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#2051Methods and compositions involving miRNA and miRNA inhibitor molecules
#2052Modulation of T cell signaling threshold and T cell sensitivity to antigens
#2053BIOMARKERS OF MIR-34 ACTIVITY
#2054Pharmaceutical Composition Comprising miRNA-100 And Its Use In The Modulation of Blood Vessel Growth and Endothelial Inflammation
#2055Treatment of vasculoproliferative conditions with Lrg1 antagonists
#2056Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#2057Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
#2058Materials and methods related to modulation of mismatch repair and genomic stability by miR-155
#2059RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
#2060MiRNAs Useful to Reduce Lung Cancer Tumorigenesis and Chemotherapy Resistance and Related Compositions and Methods
#2061MicroRNA compounds and methods for modulating miR-122
#2062Methods and compositions involving miRNA and miRNA inhibitor molecules
#2063Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
#2064Methods and agents to increase therapeutic dystrophin expression in muscle
#2065METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#2066COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LYGUS
#2067Micro-RNA Scaffolds, Non-naturally Occurring Micro-RNAs, and Methods for Optimizing Non-naturally Occurring Micro-RNAs
#2068Systems and methods for diminishing cell growth and inducing selective killing of target cells
#2069METHODS AND COMPOSITIONS TO MODULATE ANTIVIRAL AND IMMUNE ACTIVITY RESPONSES
#2070Micro-RNA scaffolds and non-naturally occurring micro-RNAs
#2071Compositions and methods for prognosis and treatment of prostate cancer
#2072Method of treating hyperlipidemia and atherosclerosis with miR-30C
#2073Compositions and methods for modulating myeloid derived suppressor cells
#2074Anti-microRNA oligonucleotide molecules
#2075Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
#2076CNS targeting AAV vectors and methods of use thereof
#2077Lin28-mediated control of let-7 biogenesis
#2078Recombinant virus products and methods for inhibition of expression of DUX4
#2079Methods and compositions involving miRNA and miRNA inhibitor molecules
#2080Characterizing melanoma
#2081Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
#2082Reduction of off-target RNA interference toxicity
#2083Inhibitors of metastasis
#2084Composition for promoting apoptosis or inhibiting cell growth, comprising epstein-barr virus microrna
#2085Methods of using microRNA 195 in providing neuroprotection
#2086Methods of treating allergic inflammatory conditions by administering an anti-cadherin-like 26-based therapeutic
#2087Compounds for the treatment of ischemic injury
#2088Composition and methods for modulating cell proliferation and cell death
#2089MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of ovarian cancer using a real-time PCR platform
#2090Oligonucleotides for modulation of target RNA activity
#2091MicroRNA-based methods and assays for osteosarcoma
#2092Gene therapy vectors and cytosine deaminases
#2093MicroRNA and methods for inhibiting same
#2094Pharmaceutical angiogenic composition including a microRNA-382 activator
#2095Methods for heart regeneration
#2096Methods and compositions for amplification and detection of MicroRNAs
#2097Methods for fixing and detecting RNA
#2098Methods for treating Niemann-Pick type C disease
#2099MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders
#2100Downregulation of miR-7 for promotion of beta cell differentiation and insulin production